New impetus for amyloid-PET imaging following the Food and Drug administration approval of a new Alzheimer’s disease treatment : Nuclear Medicine Communications

Secondary Logo

Journal Logo

Editorial

New impetus for amyloid-PET imaging following the Food and Drug administration approval of a new Alzheimer’s disease treatment

Balaji, Nikitaa,*; Balachandar, Ramyaa,*; Algodayan, Saraha,b; Lilburn, David M.L.a,c; Fraioli, Francescoa,c; Bomanji, Jamshed B.a

Author Information
Nuclear Medicine Communications 44(6):p 415-416, June 2023. | DOI: 10.1097/MNM.0000000000001688
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid